Haystack Oncology

About:

Haystack Oncology enables precision oncology to optimize treatment strategies.

Website: https://haystackoncology.com

Top Investors: Alexandria Venture Investments, Bruker, Catalio Capital Management, Exact Ventures

Description:

Haystack Oncology, an oncology company, uses the most recent circulating tumor DNA detection technology to enhance the diagnosis of minimum residual disease and provide superior therapy decision-making information.

Total Funding Amount:

$56M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

2021-01-01

Contact Email:

info(AT)haystackoncology.com

Founders:

Bert Vogelstein, Dan Edelstein, Kenneth Kinzler, Nickolas Papadopoulos

Number of Employees:

51-100

Last Funding Date:

2022-11-16

IPO Status:

Private

Industries: